Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis

Quick Facts

• Publication title: Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis
• Journal: Int Immunopharmacol
• Year: 2023
• DOI: 10.1016/j.intimp.2025.115619
• PMID/PMCID: 41046222

Research overview

This peer-reviewed publication presents research in Musculoskeletal & Orthopedics and Engineered Exosomes & Drug Delivery. Its research topic is reflected in the title: "Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis."

Echo Biotech Role

Echo Biotech contributed cargo loading; the study also used or cited ExoLoad®.

Related platforms: Echosome®, Research Reagents & Tools

Related services and capabilities: Small RNA / Cargo Loading, Research Reagent / Product Supply

Related products or reagents: ExoLoad® Nucleic Acid Loading Kit

References

Original publication: Human umbilical cord mesenchymal stem cell-derived exosomes loaded miR-451a targets ATF2 to improve rheumatoid arthritis Int Immunopharmacol. 2023. DOI: 10.1016/j.intimp.2025.115619. PMID/PMCID: 41046222.